US Stock MarketDetailed Quotes

Recursion Pharmaceuticals (RXRX)

Watchlist
  • 3.780
  • +0.180+5.00%
Close Apr 17 15:59 ET
  • 3.780
  • 0.0000.00%
Post 20:01 ET
1.99BMarket Cap-2.63P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Recursion Pharmaceuticals (RXRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
26.96%74.26M
683.66%35.35M
-80.89%4.98M
32.62%19.1M
9.84%14.82M
33.30%58.49M
-57.54%4.51M
158.19%26.08M
30.76%14.4M
11.18%13.49M
Operating revenue
26.96%74.26M
683.66%35.35M
-80.89%4.98M
32.62%19.1M
9.84%14.82M
33.30%58.49M
-57.54%4.51M
158.19%26.08M
30.76%14.4M
11.18%13.49M
Cost of revenue
56.84%70.95M
11.58%14.28M
21.59%14.69M
119.17%20.16M
95.50%21.83M
6.22%45.24M
29.48%12.79M
11.05%12.08M
-1.95%9.2M
-10.30%11.17M
Gross profit
-75.07%3.3M
354.45%21.08M
-169.30%-9.7M
-120.33%-1.06M
-401.55%-7.01M
927.93%13.25M
-1,214.80%-8.28M
1,906.84%14M
218.54%5.21M
840.45%2.33M
Operating expense
32.34%651.44M
-26.26%129.41M
44.63%162.5M
65.65%175.17M
86.85%184.36M
40.10%492.25M
76.06%175.49M
13.75%112.36M
26.87%105.75M
41.86%98.67M
Selling and administrative expenses
-0.90%176.59M
-56.39%33.66M
10.25%41.63M
46.56%46.65M
74.00%54.65M
60.78%178.18M
153.42%77.19M
29.31%37.76M
12.52%31.83M
37.31%31.41M
-General and administrative expense
-0.90%176.59M
-56.39%33.66M
10.25%41.63M
46.56%46.65M
74.00%54.65M
60.78%178.18M
153.42%77.19M
29.31%37.76M
12.52%31.83M
37.31%31.41M
Research and development costs
51.16%475.27M
-2.43%95.94M
62.28%121.06M
74.00%128.64M
91.88%129.63M
30.34%314.42M
41.52%98.33M
6.56%74.6M
34.27%73.93M
44.74%67.56M
Other operating expenses
-21.08%-425K
-434.29%-187K
---192K
-823.08%-120K
124.09%73K
49.79%-351K
86.89%-35K
----
-1,200.00%-13K
---303K
Operating profit
-35.31%-648.13M
41.05%-108.33M
-75.08%-172.2M
-75.28%-176.23M
-98.64%-191.37M
-36.83%-479M
-85.76%-183.77M
1.20%-98.35M
-23.04%-100.54M
-37.89%-96.34M
Net non-operating interest income expense
47.88%20.98M
55.87%6.26M
43.81%4.71M
72.81%4.96M
25.37%5.05M
-25.41%14.19M
-10.70%4.02M
-33.91%3.27M
-41.76%2.87M
-13.21%4.03M
Non-operating interest income
44.61%22.79M
35.22%6.25M
44.80%5.54M
66.66%5.44M
37.30%5.56M
-17.57%15.76M
2.17%4.62M
-23.13%3.83M
-34.11%3.27M
-13.13%4.05M
Non-operating interest expense
15.14%1.81M
-101.82%-11K
50.63%833K
21.83%480K
2,440.00%508K
1,520.62%1.57M
2,226.92%605K
2,112.00%553K
1,415.38%394K
5.26%20K
Other net income (expense)
-59,236.67%-17.74M
-805.50%-6.03M
983.00%5.25M
-61.48%-633K
-10,304.38%-16.33M
102.76%30K
132.55%854K
-137.57%-594K
-787.72%-392K
255.34%160K
Other non- operating income (expenses)
-59,236.67%-17.74M
-805.50%-6.03M
983.00%5.25M
-61.48%-633K
-10,304.38%-16.33M
102.76%30K
132.55%854K
-137.57%-594K
-787.72%-392K
255.34%160K
Income before tax
-38.75%-644.9M
39.57%-108.1M
-69.58%-162.25M
-75.29%-171.9M
-119.90%-202.65M
-39.94%-464.79M
-84.32%-178.9M
-2.86%-95.68M
-27.81%-98.06M
-41.06%-92.15M
Income tax
87.93%-136K
185.71%20K
-98.20%3K
0
79.72%-158K
72.26%-1.13M
100.17%7K
167K
-523K
-779K
Net income
-39.06%-644.76M
39.57%-108.12M
-69.29%-162.25M
-76.23%-171.9M
-121.60%-202.49M
-41.33%-463.66M
-92.38%-178.91M
-3.04%-95.84M
-27.13%-97.54M
-39.87%-91.37M
Net income continuous Operations
-39.06%-644.76M
39.57%-108.12M
-69.29%-162.25M
-76.23%-171.9M
-121.60%-202.49M
-41.33%-463.66M
-92.38%-178.91M
-3.04%-95.84M
-27.13%-97.54M
-39.87%-91.37M
Minority interest income
Net income attributable to the parent company
-39.06%-644.76M
39.56%-108.12M
-69.29%-162.25M
-76.23%-171.9M
-121.60%-202.49M
-41.33%-463.66M
-92.38%-178.91M
-3.04%-95.84M
-27.13%-97.54M
-39.87%-91.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-39.06%-644.76M
39.56%-108.12M
-69.29%-162.25M
-76.23%-171.9M
-121.60%-202.49M
-41.33%-463.66M
-92.38%-178.91M
-3.04%-95.84M
-27.13%-97.54M
-39.87%-91.37M
Basic earnings per share
14.79%-1.44
60.38%-0.21
-5.88%-0.36
-2.50%-0.41
-28.21%-0.5
-6.96%-1.69
-26.19%-0.53
20.93%-0.34
-5.26%-0.4
-14.71%-0.39
Diluted earnings per share
14.79%-1.44
60.38%-0.21
-5.88%-0.36
-2.50%-0.41
-28.21%-0.5
-6.96%-1.69
-26.19%-0.53
20.93%-0.34
-5.26%-0.4
-14.71%-0.39
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 26.96%74.26M683.66%35.35M-80.89%4.98M32.62%19.1M9.84%14.82M33.30%58.49M-57.54%4.51M158.19%26.08M30.76%14.4M11.18%13.49M
Operating revenue 26.96%74.26M683.66%35.35M-80.89%4.98M32.62%19.1M9.84%14.82M33.30%58.49M-57.54%4.51M158.19%26.08M30.76%14.4M11.18%13.49M
Cost of revenue 56.84%70.95M11.58%14.28M21.59%14.69M119.17%20.16M95.50%21.83M6.22%45.24M29.48%12.79M11.05%12.08M-1.95%9.2M-10.30%11.17M
Gross profit -75.07%3.3M354.45%21.08M-169.30%-9.7M-120.33%-1.06M-401.55%-7.01M927.93%13.25M-1,214.80%-8.28M1,906.84%14M218.54%5.21M840.45%2.33M
Operating expense 32.34%651.44M-26.26%129.41M44.63%162.5M65.65%175.17M86.85%184.36M40.10%492.25M76.06%175.49M13.75%112.36M26.87%105.75M41.86%98.67M
Selling and administrative expenses -0.90%176.59M-56.39%33.66M10.25%41.63M46.56%46.65M74.00%54.65M60.78%178.18M153.42%77.19M29.31%37.76M12.52%31.83M37.31%31.41M
-General and administrative expense -0.90%176.59M-56.39%33.66M10.25%41.63M46.56%46.65M74.00%54.65M60.78%178.18M153.42%77.19M29.31%37.76M12.52%31.83M37.31%31.41M
Research and development costs 51.16%475.27M-2.43%95.94M62.28%121.06M74.00%128.64M91.88%129.63M30.34%314.42M41.52%98.33M6.56%74.6M34.27%73.93M44.74%67.56M
Other operating expenses -21.08%-425K-434.29%-187K---192K-823.08%-120K124.09%73K49.79%-351K86.89%-35K-----1,200.00%-13K---303K
Operating profit -35.31%-648.13M41.05%-108.33M-75.08%-172.2M-75.28%-176.23M-98.64%-191.37M-36.83%-479M-85.76%-183.77M1.20%-98.35M-23.04%-100.54M-37.89%-96.34M
Net non-operating interest income expense 47.88%20.98M55.87%6.26M43.81%4.71M72.81%4.96M25.37%5.05M-25.41%14.19M-10.70%4.02M-33.91%3.27M-41.76%2.87M-13.21%4.03M
Non-operating interest income 44.61%22.79M35.22%6.25M44.80%5.54M66.66%5.44M37.30%5.56M-17.57%15.76M2.17%4.62M-23.13%3.83M-34.11%3.27M-13.13%4.05M
Non-operating interest expense 15.14%1.81M-101.82%-11K50.63%833K21.83%480K2,440.00%508K1,520.62%1.57M2,226.92%605K2,112.00%553K1,415.38%394K5.26%20K
Other net income (expense) -59,236.67%-17.74M-805.50%-6.03M983.00%5.25M-61.48%-633K-10,304.38%-16.33M102.76%30K132.55%854K-137.57%-594K-787.72%-392K255.34%160K
Other non- operating income (expenses) -59,236.67%-17.74M-805.50%-6.03M983.00%5.25M-61.48%-633K-10,304.38%-16.33M102.76%30K132.55%854K-137.57%-594K-787.72%-392K255.34%160K
Income before tax -38.75%-644.9M39.57%-108.1M-69.58%-162.25M-75.29%-171.9M-119.90%-202.65M-39.94%-464.79M-84.32%-178.9M-2.86%-95.68M-27.81%-98.06M-41.06%-92.15M
Income tax 87.93%-136K185.71%20K-98.20%3K079.72%-158K72.26%-1.13M100.17%7K167K-523K-779K
Net income -39.06%-644.76M39.57%-108.12M-69.29%-162.25M-76.23%-171.9M-121.60%-202.49M-41.33%-463.66M-92.38%-178.91M-3.04%-95.84M-27.13%-97.54M-39.87%-91.37M
Net income continuous Operations -39.06%-644.76M39.57%-108.12M-69.29%-162.25M-76.23%-171.9M-121.60%-202.49M-41.33%-463.66M-92.38%-178.91M-3.04%-95.84M-27.13%-97.54M-39.87%-91.37M
Minority interest income
Net income attributable to the parent company -39.06%-644.76M39.56%-108.12M-69.29%-162.25M-76.23%-171.9M-121.60%-202.49M-41.33%-463.66M-92.38%-178.91M-3.04%-95.84M-27.13%-97.54M-39.87%-91.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -39.06%-644.76M39.56%-108.12M-69.29%-162.25M-76.23%-171.9M-121.60%-202.49M-41.33%-463.66M-92.38%-178.91M-3.04%-95.84M-27.13%-97.54M-39.87%-91.37M
Basic earnings per share 14.79%-1.4460.38%-0.21-5.88%-0.36-2.50%-0.41-28.21%-0.5-6.96%-1.69-26.19%-0.5320.93%-0.34-5.26%-0.4-14.71%-0.39
Diluted earnings per share 14.79%-1.4460.38%-0.21-5.88%-0.36-2.50%-0.41-28.21%-0.5-6.96%-1.69-26.19%-0.5320.93%-0.34-5.26%-0.4-14.71%-0.39
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -